Cilansetron is a medication used to treat symptoms of irritable bowel syndrome (IBS). It is a 5-HT3 receptor antagonist, meaning it blocks the action of the neurotransmitter serotonin in the gut. This helps reduce abdominal pain, diarrhea, and other symptoms of IBS. Cilansetron is taken orally, typically in capsule form. It may take several weeks for the full effect of this medication to be seen. Side effects may include headache, nausea, and constipation.
Cilansetron is a 5-HT3 receptor antagonist that was under development by Solvay Pharmaceuticals as a potential treatment for diarrhea-predominant irritable bowel syndrome (IBS-D). However, development was discontinued in 2005 and it is not commercially available as of today.
Here's a summary of Cilansetron:
- Type of drug: 5-HT3 receptor antagonist
- Intended use: Treatment for diarrhea-predominant IBS-D (not approved)
- Development status: Discontinued in 2005
- Availability: Not commercially available
How it worked (intended mechanism):
- Cilansetron works by blocking the action of serotonin (5-HT3) receptors in the gut, which are involved in regulating gut motility and can contribute to diarrhea in IBS-D.
Important points to remember:
- Cilansetron never received regulatory approval due to concerns raised by the U.S. Food and Drug Administration (FDA).
- It is not available for prescription or purchase anywhere in the world.
- If you are experiencing IBS-D, it is crucial to consult with a healthcare professional to discuss appropriate treatment options currently available. They can advise you on various strategies like lifestyle modifications, dietary adjustments, and other medications that might be suitable for your individual case.